RCI President
Challenges Olympics to Disclose Performance Enhancing Drug Use in Games
SARATOGA
SPRINGS, NY - Noting that the Olympic Games commencing this week in London
permit some athletes to compete with performance enhancing drugs in their
systems, Ed Martin, President of Racing Commissioners International (RCI),
today urged the games to disclose the names of the affected athletes, the
competitions they are in, and the drugs in their systems.
Martin,
in testimony earlier this month, told a U.S. Senate Committee that the World
Anti-Doping Agency (WADA) has a little known policy that permits Olympic
athletes to compete with a variety of performance enhancing substances in their
bodies, something that is not allowed in horse racing except for a treatment to
mitigate bleeding.
Calling
it an “Olympic-sized deception”, Martin said, “Olympic fans won’t know who, in
what events, or the drugs in use as there is no disclosure.”
The
perception is that the Olympics are drug free. Media accounts have largely
ignored WADA’s mandate of a process where athletes can obtain a Therapeutic
Use Exemption allowing them to compete with prohibited performance
enhancing substances.
An
Olympic athlete is free to submit an application supported by their doctors and
approvals are largely controlled by his or her home Olympic committee. “If this
standard were applied in horse racing, one could argue it would be comparable
to allowing a horse owner to grant an exemption for some of his horses to run
on drugs,” Martin said.
According
to the 2010 Annual Report posted on the website of the U.S. Anti-Doping Agency
(USADA), the most requested exemption was for beta-2 agonists (i.e.
clenbuterol), followed by outright stimulants. Exemptions were requested for
anabolic agents, corticosteroids, narcotics, hormones, and platelet rich
plasma. Of those applications considered, approvals were granted more than
three times those denied, 155 to 43.
“In
horse racing there is no process to allow for therapeutic use exemptions,” the
RCI President said.
“The
trainers of horses found to have such substances in their system on raceday are
found to be in violation and sanctioned. The only exception is for a
therapeutic medication to mitigate the effect of exercise induced pulmonary
hemorrhage. Unlike the Olympics, there is disclosure in racing and horses so
treated are listed in the program for everyone to see.”
In
addition, Section 2.4 of the World Anti-Doping Code permits athletes to miss a
drug test without consequence. It is only after the third time someone has
missed a test that it becomes an actual violation. In horse racing, no race
related tests are allowed to be missed or declined.
“In
2010 U.S. racing regulators sent over 330,000 samples to the testing
laboratory. 99.5% were found to have no prohibited substance despite racing
regulators testing for more substances at deeper levels than any other sport.
When a medication violation was found, the substance was more often than not
therapeutic and theoretically might have been allowed if racing emulated the
WADA Olympic standards,” Martin noted.
According
to the USADA’s annual report for 2010 there were thirty-eight drug rule
violations out of 8,031 tests. That percentage of violators is roughly the same
as in horse racing.
“The
big exception is that racing does not have an undisclosed exemption for
therapeutic performance enhancements so not everything being used in the
Olympics is disclosed,” he said.
“When
you look at the facts, the perception that next week’s games will be drug free
and horse racing is drug ridden is an Olympic-sized deception. The challenge is
real for both, but horse racing’s transparency and hard line against virtually
all performance enhancing therapeutics may explain why some think racing’s
problem is bigger than it is,” he concluded.
No comments:
Post a Comment